Episode 38: ACM-AMIA Joint Podcast Series: Francesca Rossi
![fyi-pocast-1000x1000](https://d2vppzocvtms05.cloudfront.net/media/83077F9F-1F6E-45C6-AF09FBB2FE84364B/0F6E76A1-4829-49DF-BA3926B6A366F36F/AD785F26-27BC-4801-87EF8CC002D6968E/Small_Square-fyi-podcast-1000x1000.jpg)
AMIA received a request for information (RFI) from House of Representative Ami Bera (D- California District 6) regarding the current state of AI in health care. Aspects in the RFI include how extensively is AI implemented in health institutions, existing evidence regarding efficacy and accuracy of AI-driven health care solutions […]
Thank you for the opportunity to submit comments to the Food and Drug Administration’s (FDA) draft guidance “Collection of Race and Ethnicity Data in Clinical Trials and Clinical Studies for FDA-Regulated Medical Products.” As the leading organization of professionals working with healthcare data and protected health information (PHI), the American […]